机译:口服肽递送作为一种潜在的变革性疗法的进展和局限性
Lilly Res Labs,Eli Lilly & Co;
Oral peptide delivery; oral bioavailability; permeation enhancer; ingestible device; INTESTINAL PERMEATION ENHANCERS; EMULSIFYING DRUG-DELIVERY; GASTROINTESTINAL STABILITY; TIGHT JUNCTIONS; SODIUM CAPRATE; ABSORPTION; INSULIN; SYSTEMS; BIOAVAILABILITY; MACROMOLECULES;